Skip to main content

Silvan Tuerkcan

Stock Analyst at Oppenheimer

Total Price Targets
12
Stocks Covered
9
Sectors
Healthcare, Technology
Most Recent
Nov 5, 2025

Notable Calls (Last 12 Months)

Most Bullish

  • TERN+80.8%
    Terns Pharmaceuticals, Inc.
    $15.00 targetOct 23, 2025
  • NTLA+65.3%
    Intellia Therapeutics, Inc.
    $33.00 targetOct 6, 2025
  • EXEL-5.0%
    Exelixis, Inc.
    $36.00 targetNov 5, 2025

Most Bearish

  • EXEL-5.0%
    Exelixis, Inc.
    $36.00 targetNov 5, 2025
  • NTLA+65.3%
    Intellia Therapeutics, Inc.
    $33.00 targetOct 6, 2025
  • TERN+80.8%
    Terns Pharmaceuticals, Inc.
    $15.00 targetOct 23, 2025

Stocks Covered by Silvan Tuerkcan

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
EXELExelixis, Inc.$36.00$43.81-17.8%3Nov 5, 2025
TERNTerns Pharmaceuticals, Inc.$15.00$52.94-71.7%1Oct 23, 2025
NTLAIntellia Therapeutics, Inc.$33.00$13.20+150.0%1Oct 6, 2025
NUVBNuvation Bio Inc.$6.00$4.50+33.5%1Apr 23, 2025
ENGNenGene Holdings Inc.$18.00$7.24+148.6%1Nov 18, 2024
BNTCBenitec Biopharma Inc.$16.00$11.98+33.6%2Oct 14, 2024
ORCLOracle Corporation$80.00$172.34-53.6%1Sep 10, 2024
MGNXMacroGenics, Inc.$8.00$3.16+153.2%1Jul 31, 2024
ACRVAcrivon Therapeutics, Inc. Common Stock$17.00$2.05+729.3%1Apr 25, 2024

Recent Activity

  • Nov 5, 2025— Set$36.00price target onEXEL(Exelixis, Inc.)
  • Oct 23, 2025— Set$15.00price target onTERN(Terns Pharmaceuticals, Inc.)
  • Oct 6, 2025— Set$33.00price target onNTLA(Intellia Therapeutics, Inc.)
  • Apr 23, 2025— Set$6.00price target onNUVB(Nuvation Bio Inc.)
  • Jan 27, 2025— Set$41.00price target onEXEL(Exelixis, Inc.)
  • Nov 18, 2024— Set$18.00price target onENGN(enGene Holdings Inc.)
  • Oct 14, 2024— Set$16.00price target onBNTC(Benitec Biopharma Inc.)
  • Oct 14, 2024— Set$18.00price target onBNTC(Benitec Biopharma Inc.)
  • Sep 10, 2024— Set$80.00price target onORCL(Oracle Corporation)
  • Aug 7, 2024— Set$29.00price target onEXEL(Exelixis, Inc.)
  • Jul 31, 2024— Set$8.00price target onMGNX(MacroGenics, Inc.)
  • Apr 25, 2024— Set$17.00price target onACRV(Acrivon Therapeutics, Inc. Common Stock)

Frequently Asked Questions

Who is Silvan Tuerkcan?

Silvan Tuerkcan is a stock analyst at Oppenheimer covering 9 stocks primarily in Healthcare, Technology. They have issued 12 price targets since Apr 25, 2024.

What stocks does Silvan Tuerkcan cover?

Silvan Tuerkcan currently covers 9 stocks, including EXEL, BNTC, TERN, NTLA, NUVB.

What is Silvan Tuerkcan's latest price target?

Silvan Tuerkcan's most recent price target was $36.00 on EXEL (Exelixis, Inc.), set on Nov 5, 2025.

What is Silvan Tuerkcan's highest price target?

Silvan Tuerkcan's highest issued price target is $80.00 on ORCL, set on Sep 10, 2024.

Coverage based on publicly published price targets. Not investment advice.